Abattis Bioceuticals offers a comprehensive array of services for the cannabis industry including research & development, product formulation and regulatory & . VANCOUVER, BRITISH COLUMBIA / January 17, / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce. Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to announce that the temporary order from the British Columbia Securities.
(ATTBF ) BIOCEUTIC ABATTIS
Children, ATT is far from having been dismissed. Literally all of those things were present in. NutriVida accused of IP infringement. May be an attempt to pilfer a few. The fertilizer business is going to be Huuuuuge. Try to find any information on this "fertilizer". Sounds like we've got another bag holding newb.
Sounds like we have a hasslehoff trump fan. Convicted fraud artist at centre of crypto, cannabis. I sure as hell hope so. This subsidiary owns exclusive rights to a building material called the MgO board, which offers several advantages such as being antimicrobial, fireproof, waterproof, and recyclable.
It is a wholly owned subsidiary that supplies neutraceutical and cosmetic cannabis-based formulations. This subsidiary owns proprietary technologies for extraction, plus 13 proprietary formulations that are ready for licensing out. North America Bioextracts is also a subsidiary of Abattis. It develops and sells marijuana products such as extract oils and various flavors of vaporizers. This subsidiary operates a growing facility covering 27, square feet in Squamish, British Columbia.
This company also provides analytical services to licensed marijuana producers. ATTBF is pleased to announce the launch of its new website and provide an operational update. ATTBF is pleased to provide an update on the recent soft-launch of its cannabinoid-infused nutraceutical Comfort "Comfort" through ATTBF is pleased to announce the release of its first proprietary product, Comfort, through the Company's wholly-owned subsidiary Longer term, the trend strength is Strong.
Long term indicators fully support a continuation of the trend. Your browser of choice has not been tested for use with Barchart. If you have issues, please download one of the browsers listed here.
Try Premier Try Premier.
Abattis Bioceuticals Corp. (OTCMKTS:ATTBF)
3 days ago Abattis Bioceuticals Corp. stock price, stock quotes and financial overviews from MarketWatch. Abattis Bioceuticals Corp. Stock - ATTBF news, historical stock charts, analyst ratings, financials, and today's Abattis Bioceuticals Corp. stock price. The latest Tweets from Abattis Bioceuticals (@Abattis). Abattis Bioceuticals (CSE: ATT; OTCQX: ATTBF) is a vertically integrated public Canadian botanical drug.